Estrogen preserves Fas ligand levels by inhibiting microRNA-181a in bone marrow-derived mesenchymal stem cells to maintain bone remodeling balance

FASEB Journal

Volumn 29, Issue 9, 2015, Pages 3935-3944

  Shao, Bingyi ^a,c,d   Liao, Li ^a,b   Yu, Yang ^a,c,d   Shuai, Yi ^a,b   Su, Xiaoxia ^e   Jing, K Huan ^a,b   Yang, Deqin ^c,d   Jin, Yan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b School of Stomatology   (China)

^c CHONGQING MEDICAL UNIVERSITY   (China)

^d Chongqing Research Center for Oral Diseases and Biomedical Science   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell transplantation; Gene regulation; Osteoclast; Osteoporosis

Indexed keywords

ESTROGEN; FAS LIGAND; MESSENGER RNA; MICRORNA; MICRORNA 181A; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; FASL PROTEIN, MOUSE; MIRN181 MICRORNA, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASSAY; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE REMODELING; COCULTURE; CONTROLLED STUDY; DOWN REGULATION; ESTROGEN DEFICIENCY; FEMALE; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

3' UNTRANSLATED REGIONS; ANIMALS; BONE MARROW CELLS; BONE REMODELING; ESTROGENS; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; MESENCHYMAL STROMAL CELLS; MICE; MICRORNAS; TRANSCRIPTION, GENETIC;

EID: 84950968740     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-272823     Document Type: Article

References (37)

1. Khosla, S., Oursler, M. J., and Monroe, D. G. (2012) Estrogen and the skeleton. Trends Endocrinol. Metab. 23, 576-581
2. Sambrook, P., and Cooper, C. (2006) Osteoporosis. Lancet 367, 2010-2018
3. Novack, D. V. (2007) Estrogen and bone: osteoclasts take center stage. Cell Metab. 6,254-256
4. Kameda, T., Mano, H., Yuasa, T., Mori, Y., Miyazawa, K., Shiokawa, M., Nakamaru, Y., Hiroi, E., Hiura, K., Kameda, A., Yang, N. N., Hakeda, Y., and Kumegawa, M. (1997) Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 186, 489-495
5. Hughes, D. E., Dai, A., Tiffee, J. C., Li, H. H., Mundy, G. R., and Boyce, B. F. (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat. Med. 2, 1132-1136
6. Nakamura, T., Imai, Y., Matsumoto, T., Sato, S., Takeuchi, K., Igarashi,K.,Harada,Y.,Azuma,Y.,Krust,A.,Yamamoto,Y.,Nishina, H., Takeda, S., Takayanagi, H., Metzger, D., Kanno, J., Takaoka, K., Martin, T. J., Chambon, P., and Kato, S. (2007) Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts. Cell 130, 811-823
7. Krum,S.A.,Miranda-Carboni,G.A.,Hauschka,P.V.,Carroll,J.S., Lane, T. F., Freedman, L. P., and Brown, M. (2008) Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival. EMBO J. 27, 535-545
8. Almeida, M., Iyer, S., Martin-Millan, M., Bartell, S. M., Han, L., Ambrogini, E., Onal, M., Xiong, J., Weinstein, R. S., Jilka, R. L., O'Brien, C. A., and Manolagas, S. C. (2013) Estrogen receptor-a signaling in osteoblast progenitors stimulates cortical bone accrual. J. Clin. Invest. 123,394-404
9. Määttä, J. A., Büki, K. G., Gu, G., Alanne, M. H., Vääräniemi, J., Liljenbäck, H., Poutanen, M., Härkönen, P., and Väänänen, K. (2013) Inactivation of estrogen receptor a in bone-forming cells induces bone loss in female mice. FASEB J. 27, 478-488
10. Park, D., Spencer, J. A., Koh, B. I., Kobayashi, T., Fujisaki, J., Clemens, T. L., Lin, C. P., Kronenberg, H. M., and Scadden, D. T. (2012) Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell 10, 259-272
11. Tang, Y., Wu, X., Lei, W., Pang, L., Wan, C., Shi, Z., Zhao, L., Nagy, T.R.,Peng,X.,Hu,J.,Feng,X.,VanHul,W.,Wan,M.,andCao,X. (2009) TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15,757-765
12. Boyce, B. F., and Xing, L. (2007) Biology of RANK, RANKL, and osteoprotegerin. Arthritis Res. Ther. 9(Suppl 1), S1
13. Akiyama, K., Chen, C., Wang, D., Xu, X., Qu, C., Yamaza, T., Cai, T., Chen, W., Sun, L., and Shi, S. (2012) Mesenchymal-stem-cellinduced immunoregulation involves FAS-ligand-/FAS-mediated T cell apoptosis. Cell Stem Cell 10,544-555
14. Mödder,U.I.,Roforth,M.M.,Hoey,K.,McCready,L.K.,Peterson, J. M., Monroe, D. G., Oursler, M. J., and Khosla, S. (2011) Effects of estrogen on osteoprogenitor cells and cytokines/bone-regulatory factors in postmenopausal women. Bone 49, 202-207
15. DiGregorio,G.B.,Yamamoto,M.,Ali,A.A.,Abe,E.,Roberson,P., Manolagas, S. C., and Jilka, R. L. (2001) Attenuation of the selfrenewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol. J. Clin. Invest. 107,803-812
16. Liao,L.,Yang,X.,Su,X.,Hu,C.,Zhu,X.,Yang,N.,Chen,X.,Shi,S., Shi, S., and Jin, Y. (2013) Redundant miR-3077-5p and miR-705 mediate the shift of mesenchymal stem cell lineage commitment to adipocyte in osteoporosis bone marrow. Cell Death Dis. 4, e600
17. Kobayashi, Y., Hashimoto, F., Miyamoto, H., Kanaoka, K., Miyazaki-Kawashita, Y., Nakashima, T., Shibata, M., Kobayashi, K., Kato, Y., and Sakai, H. (2000) Force-induced osteoclast apoptosis in vivo is accompanied by elevation in transforming growth factor beta and osteoprotegerin expression. J. Bone Miner. Res. 15, 1924-1934
18. Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, G. D., Mundy, G. R., and Boyce, B. F. (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J. Bone Miner. Res. 10, 1478-1487
19. Liu, Y., Liu, W., Hu, C., Xue, Z., Wang, G., Ding, B., Luo, H., Tang, L., Kong, X., Chen, X., Liu, N., Ding, Y., and Jin, Y. (2011) MiR-17 modulates osteogenic differentiation through a coherent feedforward loop in mesenchymal stem cells isolated from periodontal ligaments of patients with periodontitis. Stem Cells 29, 1804-1816
20. Xiong,J.,Onal,M.,Jilka,R.L.,Weinstein,R.S.,Manolagas,S.C.,and O'Brien, C. A. (2011) Matrix-embedded cells control osteoclast formation. Nat. Med. 17,1235-1241
21. Bianco,P.,Cao,X.,Frenette,P.S.,Mao,J.J.,Robey,P.G.,Simmons, P. J., and Wang, C. Y. (2013) The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat. Med. 19,35-42
22. Bianco, P., Robey, P. G., and Simmons, P. J. (2008) Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2, 313-319
23. Horwitz, E. M., Gordon, P. L., Koo, W. K., Marx, J. C., Neel, M. D., McNall, R. Y., Muul, L., and Hofmann, T. (2002) Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. Natl. Acad. Sci. USA 99, 8932-8937
24. Lien, C. Y., Chih-Yuan Ho, K., Lee, O. K., Blunn, G. W., and Su, Y. (2009) Restoration of bone mass and strength in glucocorticoidtreated mice by systemic transplantation of CXCR4 and cbfa-1 coexpressing mesenchymal stem cells. J. Bone Miner. Res. 24, 837-848
25. Cho, S. W., Sun, H. J., Yang, J. Y., Jung, J. Y., An, J. H., Cho, H. Y., Choi, H. J., Kim, S. W., Kim, S. Y., Kim, D., and Shin, C. S. (2009) Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol. Ther. 17,1979-1987
26. Bartel, D. P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297
27. Lian, J. B., Stein, G. S., van Wijnen, A. J., Stein, J. L., Hassan, M. Q., Gaur, T., and Zhang, Y. (2012) MicroRNA control of bone formation and homeostasis. Nat. Rev. Endocrinol. 8, 212-227
28. Klinge, C. M. (2012) miRNAs and estrogen action. Trends Endocrinol. Metab. 23,223-233
29. Qian,P.,Zuo,Z.,Wu,Z.,Meng,X.,Li,G.,Wu,Z.,Zhang,W.,Tan,S., Pandey, V., Yao, Y., Wang, P., Zhao, L., Wang, J., Wu, Q., Song, E., Lobie, P. E., Yin, Z., and Zhu, T. (2011) Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. Cancer Res. 71, 6463-6474
30. Maillot, G., Lacroix-Triki, M., Pierredon, S., Gratadou, L., Schmidt, S., Bénès, V., Roché, H., Dalenc, F., Auboeuf, D., Millevoi, S., and Vagner, S. (2009) Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. Cancer Res. 69, 8332-8340
31. Manavalan, T. T., Teng, Y., Appana, S. N., Datta, S., Kalbfleisch, T. S., Li, Y., and Klinge, C. M. (2011) Differential expression of microRNA expression in tamoxifen-sensitive MCF-7 versus tamoxifen-resistant LY2 human breast cancer cells. Cancer Lett. 313, 26-43
32. Hah, N., Danko, C. G., Core, L., Waterfall, J. J., Siepel, A., Lis, J. T., and Kraus, W. L. (2011) A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145, 622-634
33. Yang, N., Wang, G., Hu, C., Shi, Y., Liao, L., Shi, S., Cai, Y., Cheng, S., Wang, X., Liu, Y., Tang, L., Ding, Y., and Jin, Y. (2013) Tumor necrosis factor a suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J. Bone Miner. Res. 28,559-573
34. Xian, L., Wu, X., Pang, L., Lou, M., Rosen, C. J., Qiu, T., Crane, J., Frassica, F., Zhang, L., Rodriguez, J. P., Xiaofeng Jia, Shoshana Yakar, Shouhong Xuan, Argiris Efstratiadis, Mei Wan, and Xu Cao. (2012) Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat. Med. 18, 1095-1101
35. Tomé, M., López-Romero, P., Albo, C., Sepúlveda, J. C., Fernández-Gutiérrez, B., Dopazo, A., Bernad, A., and González, M. A. (2011) miR-335 orchestrates cell proliferation, migration and differentiation in human mesenchymal stem cells. Cell Death Differ. 18,985-995
36. Van Rooij, E., and Olson, E. N. (2012) MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat. Rev. Drug Discov. 11,860-872
37. Inui, M., Martello, G., and Piccolo, S. (2010) MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11,252-263